Clinical Drug Investigation, 1179-1918


More filtering options
  1. 2020
  2. First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects

    Khalid Abd-Elaziz, Christine Voors-Pette, Kang Ling Wang, Sandy Pan, Yisheng Lee, John Mao, Yuhua Li, Benjamin Chien, David Lau & Zuzana Diamant, 2020 Dec 17, In : Clinical Drug Investigation.

    Research output: Contribution to journalArticle

  3. 2019
  4. 2017
  5. 2013
  6. 2010
  7. Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

    Hakan Walfridsson, Birgitta Johansson, Anders Englund, Goran Kenneback, Jonas Schwieler, Ole Kongstad Rasmussen, Karin Wahlander, Anders R. Malm & Nils Edvardsson, 2010, In : Clinical Drug Investigation. 30, 7, p. 461-471

    Research output: Contribution to journalArticle